                         SEQUENCE LISTING

<110>  Dosch, Hans-Michael
 
<120>  A PHASE I STUDY OF SAFETY AND PHARMACOLOGICAL ACTIVITY OF 
       SUBSTANCE P (SP) IN THE REVERSAL OF RECENT-ONSET TYPE 1
       DIABETES (T1D)

<130>  44293.01.0002

<160>  8    

<170>  PatentIn version 3.5.1

<210>  1
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs8065080_F

AGAATTGCTT GAACCCAGGA GGCA
        10         20      

<210>  2
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs8065080_R

AGCTGAGAAC CAGCAAAGCA AACC
        10         20    

<210>  3
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs224534_F

TACTTTCAAG CTTGCCTGCC TTGG
        10         20  

<210>  4
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs224534_R

ATTGTAAGAT GCTCCGCTTG GCAC
        10         20      

<210>  5
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs222749_F

GCAAGGATGA AGAAATGGAG CAGC
        10         20    

<210>  6
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs222749_R

AAGTCCAAGT GTCTGTGGCT GGTA
        10         20    

<210>  7
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs222747_F

TTTGGGCAGA GACAGAGGGA GTTT
        10         20    

<210>  8
<211>  24
<212>  DNA
<213>  Artificial sequence

<400>  rs222747_R

TTCTTCTGTT CCACCCTAGG CAGT
        10         20    
